Ensayos clínicos de Migraña en Virginia
7 estudios sobre Migraña buscan participantes en Virginia.
Ciudades en Virginia
Texto oficial del estudio (inglés)
Study of EVO756 in Adults With Migraine
- MedStar Health: Headache Center at McLean, McLean
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07616128A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Health Research of Hampton Roads, Inc. (HRHR), Newport News
- AMR Clinical - Norfolk, Norfolk
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- y 2 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- y 2 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 27 oct 2026 · NCT04649242A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Children's Specialty Group (CSG), Norfolk
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 oct 2026 · NCT05164172Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
- Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 230581, Norfolk
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05125302Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
- MedStar Health: Neurology at McLean, McLean
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 dic 2025 · NCT07301008De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.